Oral Nemonoxacin in Treating Elderly Patients With CAP

• Status: Completed
• Trial end date: 2020-03-23
• Target enrollment: 0
• Participant gender: All

Summary

This study was to evaluate the safety and efficacy of oral nemonoxacin in treating elderly patients (aged ≥ 65 years) with community-acquired pneumonia (CAP).

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: TaiGen Biotechnology Co., Ltd.

Criteria

Inclusion Criteria:

• Age ≥65 years

• Clinical diagnosis of CAP

• Evidence of inflammatory exudates or infiltrates on chest X-ray

Exclusion Criteria:

• Suspect viral pneumonia, aspiration pneumonia, ventilator-associated pneumonia or hospital-acquired pneumonia

• History of hypersensitivity to quinolone or fluoroquinolone